跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZILBRYSQ 16,6 MG, SOLUCION INYECTABLE EN JERINGA PRECARGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ZILBRYSQ 16,6 MG, SOLUCION INYECTABLE EN JERINGA PRECARGADA
Approved
STANDARD
ZILBRYSQ 16,6 MG, SOLUCION INYECTABLE EN JERINGA PRECARGADA
Ucb Pharma
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 22, 2023
Approval ID
650ffe9b218da7e7
Company
Ucb Pharma
Type
Standard
Approval Details
Approval Id
650ffe9b218da7e7
Drug Cima Aemps Name
ZILBRYSQ 16,6 MG, SOLUCION INYECTABLE EN JERINGA PRECARGADA
Register Number
1231764001
Holder Company Name
Ucb Pharma
Marketing Company Name
Ucb Pharma S.A.
Holder Company Detail Path
/organization/ucb-pharma-sa
Marketing Company Detail Path
/organization/ucb-pharma-sa-switzerland
Authorization Date
2023-12-22
Dosage Form
SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA
Dose
16,6 mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Ucb Pharma
Company Detail Path
/organization/ucb-pharma-sa
Company Information
Pharmaceutical Company Name
UCB S.A.
Name En
UCB S.A.
Country Name
Belgium
City Name
Brussels
Address
Brussels, Belgium
Website
https://www.ucb.com
Active Ingredients
ZILUCOPLAN
16,64 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 22, 2023
Approval ID
650ffe9b218da7e7
Type
Standard
Back to CIMA-AEMPS Approvals